Skip to content
Back to glossary
Biomarkers

Fibrinogen

Fibrinogen (also called clotting factor I) is a large protein your liver makes that turns into fibrin, the mesh that forms a blood clot. It is also an 'acute-phase reactant', meaning it rises with inflammation. Labs measure it with the Clauss clot-based test or an immunoassay, and the usual range is 200 to 400 mg/dL (2.0 to 4.0 g/L). Beyond clotting, your fibrinogen level is an independent heart-risk marker. A large pooled analysis of 154,211 adults (the Fibrinogen Studies Collaboration, JAMA 2005) found that every 1 g/L higher fibrinogen carried about a 2.4-fold higher risk of coronary heart disease (95% CI 2.3 to 2.6), with similar links to stroke and non-vascular death. Watch the confounders, though: infection or injury push it up within a day or two, as do smoking, pregnancy, oral estrogen, cancer, and chronic inflammation. It drops in conditions like widespread clotting (DIC), severe liver disease, clot-busting therapy, and the inherited low-fibrinogen disorder.

Last reviewed:

This definition is educational and is not medical advice, a diagnosis, or treatment. Talk to a doctor about any health decisions. Read our full medical disclaimer

Sources

  1. Fibrinogen Studies Collaboration (Danesh J, Lewington S, Thompson SG, et al.). (2005). Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. *JAMA*doi:10.1001/jama.294.14.1799
  2. Kaptoge S, Di Angelantonio E, Pennells L, et al. (Emerging Risk Factors Collaboration). (2012). C-reactive protein, fibrinogen, and cardiovascular disease prediction. *New England Journal of Medicine*doi:10.1056/NEJMoa1107477